<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Circulation</journal-id><journal-id journal-id-type="iso-abbrev">Circulation</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Circulation</journal-title></journal-title-group><issn pub-type="ppub">0009-7322</issn><issn pub-type="epub">1524-4539</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10133018</article-id><article-id pub-id-type="pmcid-ver">PMC10133018.1</article-id><article-id pub-id-type="pmcaid">10133018</article-id><article-id pub-id-type="pmcaiid">10133018</article-id><article-id pub-id-type="manuscript-id">NIHMS1876098</article-id><article-id pub-id-type="pmid">36866664</article-id><article-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.062123</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1876098</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1876098</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries: The SAFE-AAA Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Secemsky</surname><given-names initials="EA">Eric A.</given-names></name><degrees>MD MSc</degrees><role>Assistant Professor</role><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="Y">Yang</given-names></name><degrees>MSc</degrees><role>Assistant Professor</role><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="T">Tianyu</given-names></name><degrees>PhD</degrees><role>Assistant Professor</role><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gacchina Johnson</surname><given-names initials="C">Carmen</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gatski</surname><given-names initials="M">Megan</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="L">Li</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Farb</surname><given-names initials="A">Andrew</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="RE">Robert E.</given-names></name><degrees>MD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shaw</surname><given-names initials="A">Aurko</given-names></name><degrees>MTM</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="J">Jiaman</given-names></name><degrees>MPH</degrees><role>Assistant Professor</role><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yeh</surname><given-names initials="RW">Robert W.</given-names></name><degrees>MD MSc</degrees><role>Assistant Professor</role><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Department of Medicine; Beth Israel Deaconess Medical Center, Boston, MA, USA;</aff><aff id="A2"><label>2</label>Harvard Medical School, Boston, MA, USA</aff><aff id="A3"><label>3</label>Division of Cardiology, Department of Medicine; Beth Israel Deaconess Medical Center, Boston, MA, USA</aff><aff id="A4"><label>4</label>Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD, USA</aff><author-notes><corresp id="CR1"><bold>Address for Correspondence:</bold> Eric A. Secemsky, MD, MSc, Director of Vascular Intervention, Beth Israel Deaconess Medical Center, Section Head, Interventional Cardiology and Vascular Research, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Assistant Professor of Medicine, Harvard Medical School, 375 Longwood Avenue, 4th Floor, Boston, MA 02215, Tel: 617-632-7393, Fax: 617-632-7620, <email>esecemsk@bidmc.harvard.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>25</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>03</day><month>3</month><year>2023</year></pub-date><volume>147</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">434403</issue-id><fpage>1264</fpage><lpage>1276</lpage><pub-history><event event-type="nihms-submitted"><date><day>21</day><month>02</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>25</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>25</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-29 13:25:22.113"><day>29</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1876098.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Concerns have been raised about the long-term performance of aortic stent grafts for the treatment of abdominal aortic aneurysms, in particular unibody stent grafts (e.g. Endologix AFX AAA Stent Grafts). Only limited datasets are available to evaluate the long-term risks related to these devices. The SAFE-AAA Study was designed with the Food &amp; Drug Administration to provide a longitudinal assessment of the safety of unibody aortic stent grafts among Medicare beneficiaries.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">The SAFE-AAA Study was a pre-specified, retrospective cohort study evaluating whether unibody aortic stent grafts are non-inferior (NI) to non-unibody stent grafts with respect to the composite primary outcome of aortic reintervention, rupture and mortality. Procedures were evaluated from August 1, 2011 through December 31, 2017. The primary endpoint was evaluated through December 31, 2019. Inverse probability weighting was used to account for imbalances in observed characteristics. Sensitivity analyses were used to evaluate the impact of unmeasured confounding, including the falsification endpoints of heart failure, stroke and pneumonia. A pre-specified subgroup includes patients treated from February 22, 2016 through December 31, 2017, corresponding to the market release of the most contemporary unibody endograft (Endologix AFX2 AAA Stent Graft).</p></sec><sec id="S3"><title>Results:</title><p id="P3">Of 87,163 patients who underwent aortic stent grafting at 2,146 US hospitals, 11,903 (13.7%) received a unibody device. The average age was 77.0 &#177; 6.7 years, 21.1% were female, 93.5% were white, 90.8% had hypertension and 35.8% used tobacco. The primary endpoint occurred in 73.4% of unibody device-treated patients versus 65.0% of non-unibody device-treated patients (HR 1.19, 95% CI 1.15, 1.22, NI p-value of 1.00, median follow-up 3.4 years). Falsification endpoints were negligibly different between groups. In a contemporary subgroup of procedures, the cumulative incidence of the primary endpoint was 37.5% of unibody device-treated patients and 32.7% of non-unibody device-treated patients (HR 1.06, 95%CI 0.98, 1.14).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">In the SAFE-AAA Study, unibody endografts failed to meet non-inferiority when compared to non-unibody endografts with respect to aortic reintervention, rupture and mortality. These data support the urgency of instituting a prospective longitudinal surveillance program for monitoring safety events related to aortic stent grafts.</p></sec></abstract><kwd-group><kwd>abdominal aortic aneurysm</kwd><kwd>comparative analysis</kwd><kwd>endografts</kwd><kwd>outcomes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>